Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer
Timothy R Rebbeck,Nandita Mitra,Fei Wan,Olga M Sinilnikova,Sue Healey,Lesley McGuffog,Sylvie Mazoyer,Georgia Chenevix-Trench,Douglas F Easton,Antonis C Antoniou,Katherine L Nathanson,CIMBA Consortium,Yael Laitman,Anya Kushnir,Shani Paluch-Shimon,Raanan Berger,Jamal Zidan,Eitan Friedman,Hans Ehrencrona,Marie Stenmark-Askmalm,Zakaria Einbeigi,Niklas Loman,Katja Harbst,Johanna Rantala,Beatrice Melin,Dezheng Huo,Olufunmilayo I Olopade,Joyce Seldon,Patricia A Ganz,Robert L Nussbaum,Salina B Chan,Kunle Odunsi,Simon A Gayther,Susan M Domchek,Banu K Arun,Karen H Lu,Gillian Mitchell,Beth Y Karlan,Christine Walsh,Jenny Lester,Andrew K Godwin,Harsh Pathak,Eric Ross,Mary B Daly,Alice S Whittemore,Esther M John,Alexander Miron,Mary Beth Terry,Wendy K Chung,David E Goldgar,Saundra S Buys,Ramunas Janavicius,Laima Tihomirova,Nadine Tung,Cecilia M Dorfling,Elizabeth J van Rensburg,Linda Steele,Susan L Neuhausen,Yuan Chun Ding,Bent Ejlertsen,Anne-Marie Gerdes,Thomas v O Hansen,Teresa Ramón y Cajal,Ana Osorio,Javier Benitez,Javier Godino,Maria-Isabel Tejada,Mercedes Duran,Jeffrey N Weitzel,Kristie A Bobolis,Sharon R Sand,Annette Fontaine,Antonella Savarese,Barbara Pasini,Bernard Peissel,Bernardo Bonanni,Daniela Zaffaroni,Francesca Vignolo-Lutati,Giulietta Scuvera,Giuseppe Giannini,Loris Bernard,Maurizio Genuardi,Paolo Radice,Riccardo Dolcetti,Siranoush Manoukian,Valeria Pensotti,Viviana Gismondi,Drakoulis Yannoukakos,Florentia Fostira,Judy Garber,Diana Torres,Muhammad Usman Rashid,Ute Hamann,Susan Peock,Debra Frost,Radka Platte,D Gareth Evans,Rosalind Eeles,Rosemarie Davidson,Diana Eccles,Trevor Cole,Jackie Cook,Carole Brewer,Shirley Hodgson,Patrick J Morrison,Lisa Walker,Mary E Porteous,M John Kennedy,Louise Izatt,Julian Adlard,Alan Donaldson,Steve Ellis,Priyanka Sharma,Rita Katharina Schmutzler,Barbara Wappenschmidt,Alexandra Becker,Kerstin Rhiem,Eric Hahnen,Christoph Engel,Alfons Meindl,Stefanie Engert,Nina Ditsch,Norbert Arnold,Hans Jörg Plendl,Christoph Mundhenke,Dieter Niederacher,Markus Fleisch,Christian Sutter,C R Bartram,Nicola Dikow,Shan Wang-Gohrke,Dorothea Gadzicki,Doris Steinemann,Karin Kast,Marit Beer,Raymonda Varon-Mateeva,Andrea Gehrig,Bernhard H Weber,Dominique Stoppa-Lyonnet,Claude Houdayer,Muriel Belotti,Marion Gauthier-Villars,Francesca Damiola,Nadia Boutry-Kryza,Christine Lasset,Hagay Sobol,Jean-Philippe Peyrat,Danièle Muller,Jean-Pierre Fricker,Marie-Agnès Collonge-Rame,Isabelle Mortemousque,Catherine Nogues,Etienne Rouleau,Claudine Isaacs,Anne De Paepe,Bruce Poppe,Kathleen Claes,Kim De Leeneer,Marion Piedmonte,Gustavo Rodriguez,Katie Wakely,John Boggess,Stephanie V Blank,Jack Basil,Masoud Azodi,Kelly-Anne Phillips,Trinidad Caldes,Miguel de la Hoya,Atocha Romero,Heli Nevanlinna,Kristiina Aittomäki,Annemarie H van der Hout,Frans B L Hogervorst,Senno Verhoef,J Margriet Collée,Caroline Seynaeve,Jan C Oosterwijk,Johannes J P Gille,Juul T Wijnen,Encarna B Gómez Garcia,Carolien M Kets,Margreet G E M Ausems,Cora M Aalfs,Peter Devilee,Arjen R Mensenkamp,Ava Kwong,Edith Olah,Janos Papp,Orland Diez,Conxi Lazaro,Esther Darder,Ignacio Blanco,Mónica Salinas,Anna Jakubowska,Jan Lubinski,Jacek Gronwald,Katarzyna Jaworska-Bieniek,Katarzyna Durda,Grzegorz Sukiennicki,Tomasz Huzarski,Tomasz Byrski,Cezary Cybulski,Aleksandra Toloczko-Grabarek,Elżbieta Złowocka-Perłowska,Janusz Menkiszak,Adalgeir Arason,Rosa B Barkardottir,Jacques Simard,Rachel Laframboise,Marco Montagna,Simona Agata,Elisa Alducci,Ana Peixoto,Manuel R Teixeira,Amanda B Spurdle,Min Hyuk Lee,Sue K Park,Sung-Won Kim,Tara M Friebel,Fergus J Couch,Noralane M Lindor,Vernon S Pankratz,Lucia Guidugli,Xianshu Wang,Marc Tischkowitz,Lenka Foretova,Joseph Vijai,Kenneth Offit,Mark Robson,Rohini Rau-Murthy,Noah Kauff,Anneliese Fink-Retter,Christian F Singer,Christine Rappaport,Daphne Gschwantler-Kaulich,Georg Pfeiler,Muy-Kheng Tea,Andreas Berger,Mark H Greene,Phuong L Mai,Evgeny N Imyanitov,Amanda Ewart Toland,Leigha Senter,Anders Bojesen,Inge Sokilde Pedersen,Anne-Bine Skytte,Lone Sunde,Mads Thomassen,Sanne Traasdahl Moeller,Torben A Kruse,Uffe Birk Jensen,Maria Adelaide Caligo,Paolo Aretini,Soo-Hwang Teo,Christina G Selkirk,Peter J Hulick,Irene Andrulis
DOI: https://doi.org/10.1001/jama.2014.5985
IF: 11.816
2015-04-07
JAMA
Abstract:Importance: Limited information about the relationship between specific mutations in BRCA1 or BRCA2 (BRCA1/2) and cancer risk exists. Objective: To identify mutation-specific cancer risks for carriers of BRCA1/2. Design, setting, and participants: Observational study of women who were ascertained between 1937 and 2011 (median, 1999) and found to carry disease-associated BRCA1 or BRCA2 mutations. The international sample comprised 19,581 carriers of BRCA1 mutations and 11,900 carriers of BRCA2 mutations from 55 centers in 33 countries on 6 continents. We estimated hazard ratios for breast and ovarian cancer based on mutation type, function, and nucleotide position. We also estimated RHR, the ratio of breast vs ovarian cancer hazard ratios. A value of RHR greater than 1 indicated elevated breast cancer risk; a value of RHR less than 1 indicated elevated ovarian cancer risk. Exposures: Mutations of BRCA1 or BRCA2. Main outcomes and measures: Breast and ovarian cancer risks. Results: Among BRCA1 mutation carriers, 9052 women (46%) were diagnosed with breast cancer, 2317 (12%) with ovarian cancer, 1041 (5%) with breast and ovarian cancer, and 7171 (37%) without cancer. Among BRCA2 mutation carriers, 6180 women (52%) were diagnosed with breast cancer, 682 (6%) with ovarian cancer, 272 (2%) with breast and ovarian cancer, and 4766 (40%) without cancer. In BRCA1, we identified 3 breast cancer cluster regions (BCCRs) located at c.179 to c.505 (BCCR1; RHR = 1.46; 95% CI, 1.22-1.74; P = 2 × 10(-6)), c.4328 to c.4945 (BCCR2; RHR = 1.34; 95% CI, 1.01-1.78; P = .04), and c. 5261 to c.5563 (BCCR2', RHR = 1.38; 95% CI, 1.22-1.55; P = 6 × 10(-9)). We also identified an ovarian cancer cluster region (OCCR) from c.1380 to c.4062 (approximately exon 11) with RHR = 0.62 (95% CI, 0.56-0.70; P = 9 × 10(-17)). In BRCA2, we observed multiple BCCRs spanning c.1 to c.596 (BCCR1; RHR = 1.71; 95% CI, 1.06-2.78; P = .03), c.772 to c.1806 (BCCR1'; RHR = 1.63; 95% CI, 1.10-2.40; P = .01), and c.7394 to c.8904 (BCCR2; RHR = 2.31; 95% CI, 1.69-3.16; P = .00002). We also identified 3 OCCRs: the first (OCCR1) spanned c.3249 to c.5681 that was adjacent to c.5946delT (6174delT; RHR = 0.51; 95% CI, 0.44-0.60; P = 6 × 10(-17)). The second OCCR spanned c.6645 to c.7471 (OCCR2; RHR = 0.57; 95% CI, 0.41-0.80; P = .001). Mutations conferring nonsense-mediated decay were associated with differential breast or ovarian cancer risks and an earlier age of breast cancer diagnosis for both BRCA1 and BRCA2 mutation carriers. Conclusions and relevance: Breast and ovarian cancer risks varied by type and location of BRCA1/2 mutations. With appropriate validation, these data may have implications for risk assessment and cancer prevention decision making for carriers of BRCA1 and BRCA2 mutations.